Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950168-02-000198
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 ROBERT L. RUSCHER dsc13ga.txt SC 13G/A 10266
  Complete submission text file 0000950168-02-000198.txt   12174
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53269 | Film No.: 02547346
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7808 HARDWICK DR RALEIGH NC 27615
Business Address 7807 HARDWICK DR RALEIGH NC 27615 6508561550
RUSCHER ROBERT L (Filed by) CIK: 0001106813 (see all company filings)